Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FQ93Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,503
Award facts
- Contract value 100% obligated
- $6,502.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 10, 2025, for Zepbound 5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with a ceiling value of $6,502.58 and an ultimate completion date of November 12, 2025. This award was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements in open competition. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at approximately $1 billion through December 2026.
AmerisourceBergen's federal contract portfolio demonstrates extensive experience supplying pharmaceutical products and medical supplies to support military and veteran healthcare systems. Through its DLA IDC, the company provides a wide spectrum of medications across multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Zepbound delivery order exemplifies the company's role in supplying critical pharmaceutical commodities to federal health programs, with the DLA planning to establish future Pharmaceutical Prime Vendor Global Program Generation V contracts with potential multiple awards across separate regions.
Quick answers
Who was awarded contract SPE2DB26FQ93Q?
SPE2DB26FQ93Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FQ93Q worth?
The government has obligated $6,503 on SPE2DB26FQ93Q.
Is contract SPE2DB26FQ93Q an order under another contract?
Yes. SPE2DB26FQ93Q is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ93Q competed?
The extent of competition for SPE2DB26FQ93Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award